Leerink Partners Downgrades Terns Pharmaceuticals (TERN) to Market Perform

April 8, 2026 9:59 AM

Leerink Partners analyst Andrew Berens downgraded Terns Pharmaceuticals (NASDAQ: TERN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found